- Low-dose triple drug combination targeting the PI3K/AKT/mTOR pathway and the MAPK pathway is an effective approach in ovarian clear cell carcinoma
- Equivalent Long-term Transplantation Outcomes for Kidneys Donated After Brain Death and Cardiac Death: Conclusions From a Nationwide Evaluation
- Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient
- Growth factors of stem cell niche extend the life-span of precision-cut intestinal slices in culture: A proof-of-concept study
- Quantification of surfactant protein D (SPD) in human serum by liquid chromatography-mass spectrometry (LC-MS)
- Long-term prevention of capsular opacification after lens-refilling surgery in a rabbit model
- White matter architecture in major depression with anxious distress symptoms
- Handrail Holding during Treadmill Walking Reduces Locomotor Learning in Able-Bodied Persons
- Early detection of heart function abnormality by native T1: a comparison of two T1 quantification methods
- The Wayfinding Questionnaire: A clinically useful self-report instrument to identify navigation complaints in stroke patients
Most Used Journals
Bio-inspired pulmonary surfactant-modified nanogels: a promising siRNA delivery system.
J Control Release. 2015 Mar 16;
Authors: De Backer L, Braeckmans K, Stuart MC, Demeester J, De Smedt SC, Raemdonck K
Inhalation therapy with small interfering RNA (siRNA) is a promising approach in the treatment of pulmonary disorders. However, clinical translation is severely limited by the lack of suitable delivery platforms. In this study, we aim to address this limitation by designing a novel bioinspired hybrid nanoparticle with a core-shell nanoarchitecture, consisting of a siRNA-loaded dextran nanogel (siNG) core and a pulmonary surfactant (Curosurf®) outer shell. The decoration of siNGs with a surfactant shell enhances the colloidal stability and prevents siRNA release in the presence of competing polyanions, which are abundantly present in biofluids. Additionally, the impact of the surfactant shell on the biological efficacy of the siNGs is determined in lung cancer cells. The presence of the surfactants substantially reduces the cellular uptake of siNGs. Remarkably, the lowered intracellular dose does not impede the gene silencing effect, suggesting a crucial role of the pulmonary surfactant in the intracellular processing of the nanoparticles. In order to surmount the observed reduction in cellular dose, folate is incorporated as a targeting ligand in the pulmonary surfactant shell to incite receptor-mediated endocytosis. The latter substantially enhances both cellular uptake and gene silencing potential, achieving efficient knockdown at siRNA concentrations in the low nanomolar range.
PMID: 25791835 [PubMed – as supplied by publisher]